Poupiot J - Search Results

1

An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species.

Vu Hong A, Suel L, Petat E, Dubois A, Le Brun PR, Guerchet N, Veron P, Poupiot J, Richard I. Vu Hong A, et al. Among authors: poupiot j. Nat Commun. 2024 Sep 11;15(1):7965. doi: 10.1038/s41467-024-52002-4. Nat Commun. 2024. PMID: 39261465 Free PMC article.

2

Methods for noninvasive monitoring of muscle fiber survival with an AAV vector encoding the mSEAP reporter gene.

Poupiot J, Ausseil J, Richard I. Poupiot J, et al. Methods Mol Biol. 2011;709:63-74. doi: 10.1007/978-1-61737-982-6_4. Methods Mol Biol. 2011. PMID: 21194021

3

Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy.

Roudaut C, Le Roy F, Suel L, Poupiot J, Charton K, Bartoli M, Richard I. Roudaut C, et al. Among authors: poupiot j. Circulation. 2013 Sep 3;128(10):1094-104. doi: 10.1161/CIRCULATIONAHA.113.001340. Epub 2013 Aug 1. Circulation. 2013. PMID: 23908349

4

Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.

Bartoli M, Roudaut C, Martin S, Fougerousse F, Suel L, Poupiot J, Gicquel E, Noulet F, Danos O, Richard I. Bartoli M, et al. Among authors: poupiot j. Mol Ther. 2006 Feb;13(2):250-9. doi: 10.1016/j.ymthe.2005.09.017. Epub 2005 Nov 14. Mol Ther. 2006. PMID: 16290124 Free article.

5

Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Among authors: poupiot j. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Mol Ther. 2007. PMID: 17164775 Free article.

6

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.

Israeli D, Poupiot J, Amor F, Charton K, Lostal W, Jeanson-Leh L, Richard I. Israeli D, et al. Among authors: poupiot j. Sci Rep. 2016 Jun 21;6:28097. doi: 10.1038/srep28097. Sci Rep. 2016. PMID: 27323895 Free PMC article.

7

Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy.

Vu Hong A, Bourg N, Sanatine P, Poupiot J, Charton K, Gicquel E, Massourides E, Spinazzi M, Richard I, Israeli D. Vu Hong A, et al. Among authors: poupiot j. Life Sci Alliance. 2022 Oct 20;6(1):e202201506. doi: 10.26508/lsa.202201506. Print 2023 Jan. Life Sci Alliance. 2022. PMID: 36265896 Free PMC article.

8

Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transfer.

Boisgerault F, Gross DA, Ferrand M, Poupiot J, Darocha S, Richard I, Galy A. Boisgerault F, et al. Among authors: poupiot j. Hum Gene Ther. 2013 Apr;24(4):393-405. doi: 10.1089/hum.2012.208. Hum Gene Ther. 2013. PMID: 23427817

9

Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Among authors: poupiot j. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Epub 2016 Dec 8. Mol Ther. 2007. PMID: 28182933

10

Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.

Bartoli M, Poupiot J, Goyenvalle A, Perez N, Garcia L, Danos O, Richard I. Bartoli M, et al. Among authors: poupiot j. Gene Ther. 2006 Jan;13(1):20-8. doi: 10.1038/sj.gt.3302594. Gene Ther. 2006. PMID: 16107863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters